📰 Enavate Sciences News
Enavate Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Enavate Sciences. Real-time updates on events, politics, business and more.
February 13, 2024
The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...
January 3, 2024
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
December 20, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
December 20, 2023
The university’s $17.9 billion endowment has also invested directly in OpenAI and in OpenAI’s corporate venture fund, documents show.
November 9, 2023
InnovationRx is your weekly digest of healthcare news. Sign up!
November 9, 2023
Since June, the Committee has subpoenaed documents from McKinsey, Curinos, BlackRock, Ernest & Young, and Goldman Sachs to unearth all available information.
November 8, 2023
OrsoBio has raised $60m in Series A financing to advance its metabolic portfolio for the treatment of obesity and associated disorders.
November 7, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
June 29, 2023
Biopharmaceutical company Immunome (IMNM) and private biotechnology company Morphimmune announced Thursday that they have entered into a definitive merger agreement to combine in an all-stock transaction.